In an interview with Targeted Oncology at the 2025 North American Neuroendocrine Tumor Society (NANETS) Symposium, Michael ...
Children’s Hospital Los Angeles (CHLA) is expanding its safety protocol for patients receiving Elevidys®, the FDA-approved ...
A hospital in Thailand created a quick-action dialysis protocol for patients with metformin-associated lactic acidosis, a ...
Liver cancer screening uses ultrasound and AFP biomarker tests, with CT or MRI for further evaluation if abnormalities are ...
A new study reveals that exposure to tetrachloroethylene (PCE), found in dry cleaning and household products, can triple the risk of severe liver scar ...
Company Hosting Virtual KOL Panel Event Thursday, November 13th at 10:00 AM ETBOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Atea ...
Intellia earlier this year reported a similar grade 4 liver enzyme elevation associated with the gene therapy nexiguran ...
Intellia Therapeutics has temporarily stopped dosing and patient screening in two late-stage studies of its gene therapy after a participant developed serious liver injury, the company said on Monday, ...
Experts explore a novel combined therapy for liver-dominant neuroendocrine tumors, enhancing treatment durability with chemotherapy and PRRT. In an interview with Targeted Oncology at the 2025 North ...
Intellia Therapeutics has acknowledged the death of the elderly patient hospitalized last week in its Phase III trial of assessing nexiguran ziclumeran (nex-z) in transthyretin amyloidosis with ...
2dOpinion
My infant son died of a rare disorder — I wish his doctors had run this cheap test sooner
"It was a very big wake-up call," Jordan Kruse told The Post. "Life was structured a lot differently than what we expected it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback